Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: A meta-analysis

Breast Cancer Research and Treatment

Volumn 134, Issue 3, 2012, Pages 957-967

  Chen, Xiaosong ^a   Yuan, Ying ^b   Gu, Zhaoxiang ^c   Shen, Kunwei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Biopsy; Breast Neoplasm; Concordance; Hormonal receptor; Human epidermal growth factor receptor 2; Meta analysis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BIOPSY TECHNIQUE; BREAST BIOPSY; BREAST CANCER; CONTROLLED STUDY; CORE NEEDLE BIOPSY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; META ANALYSIS; OPEN EXCISION BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

BIOPSY, LARGE-CORE NEEDLE; BREAST NEOPLASMS; FEMALE; HUMANS; ODDS RATIO; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY;

EID: 84868209856     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-1990-z     Document Type: Article

References (44)

1. Harris L, Fritsche H, Mennel R et al (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25(33):5287-5312
2. Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747-752
3. Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874
4. Sorlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418-8423
5. Goldhirsch A, Wood WC, Coates AS et al (2011) Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22(8):1736-1747
6. Bruening W, Fontanarosa J, Tipton K et al (2010) Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med 152(4):238-246
7. Mueller-Holzner E, Fink V, Frede T et al (2001) Immunohistochemical determination of HER2 expression in breast cancer from core biopsy specimens: a reliable predictor of HER2 status of the whole tumor. Breast Cancer Res Treat 69(1):13-19
8. Cahill RA, Walsh D, Landers RJ et al (2006) Preoperative profiling of symptomatic breast cancer by diagnostic core biopsy. Ann Surg Oncol 13(1):45-51
9. Lorgis V, Algros MP, Villanueva C et al (2011) Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour. Breast 20(3):284-287
10. Zamora J, Abraira V, Muriel A et al (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31
11. Taucher S, Rudas M, Mader RM et al (2004) Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer. Wien Klin Wochenschr 116 (1-2):26-31
12. Shet T, Agrawal A, Chinoy R et al (2007) Changes in the tumor grade and biological markers in locally advanced breast cancer after chemotherapy- implications for a pathologist. Breast J 13(5):457-464
13. Taucher S, Rudas M, Gnant M et al (2003) Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy. Endocr Relat Cancer 10(1):91-98
14. Burge CN, Chang HR, Apple SK (2006) Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens? Breast 15(2):167-172
15. Di Loreto C, Puglisi F, Rimondi G et al (1996) Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas. Eur J Cancer 32 A (10):1693-1700
16. Railo M, Nordling S, Krogerus L et al (1996) Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen. Diagn Cytopathol 15(3):205-210
17. Zidan A, Christie Brown JS et al (1997) Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma. J Clin Pathol 50(1):27-29
18. Al Sarakbi W, Salhab M, Thomas V et al (2005) Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer? Int Semin Surg Oncol 22(2):15
19. Mann GB, Fahey VD, Feleppa F et al (2005) Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer. J Clin Oncol 23(22):5148-5154
20. Badoual C, Maruani A, Ghorra C et al (2005) Pathological prognostic factors of invasive breast carcinoma in ultrasoundguided large core biopsies-correlation with subsequent surgical excisions. Breast 14(1):22-27
21. Usami S, Moriya T, Amari M et al (2007) Reliability of prognostic factors in breast carcinoma determined by core needle biopsy. Jpn J Clin Oncol 37(4):250-255
22. Wood B, Junckerstorff R, Sterrett G et al (2007) A comparison of immunohistochemical staining for oestrogen receptor, progesterone receptor and HER-2 in breast core biopsies and subsequent excisions. Pathology 39(4):391-395
23. Hodi Z, Chakrabarti J, Lee AH, Ronan JE et al (2007) The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast. J Clin Pathol 60(3):299-302
24. Sutela A, Vanninen R, Sudah M et al (2008) Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer. Acta Oncol 47(1):38-46
25. Abdsaleh S, Wärnberg F, Azavedo E et al (2008) Comparison of core needle biopsy and surgical specimens in malignant breast lesions regarding histological features and hormone receptor expression. Histopathology 52(6):773-775
26. Hanley KZ, Birdsong GG, Cohen C et al (2009) Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas: comparison on cell block, needle-core, and tissue block preparations. Cancer 117(4):279-288
27. Park SY, Kim KS, Lee TG, Park SS, Kim SM, Han W, Noh DY, Kim SW et al (2009) The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer. Am J Surg 197(2):266-269
28. Arnedos M, Nerurkar A, Osin P et al (2009) Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Ann Oncol 20(12):1948-1952
29. Richter-Ehrenstein C, Müller S, Noske A et al (2009) Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients. Int J Surg Pathol 4:323-326
30. Apple SK, Lowe AC, Rao PN et al (2009) Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer. Mod Pathol 22(9):1151-1159
31. Tsuda H, Kurosumi M, Umemura S et al (2010) HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens. BMC Cancer 10:534
32. Lebeau A, Turzynski A, Braun S et al (2010) Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies. J Clin Oncol 28(20):3264-3270
33. Zagouri F, Sergentanis TN, Nonni A et al (2010) Comparison of molecular markers expression in vacuum-assisted biopsies and surgical specimens of human breast carcinomas. Pathol Res Pract 206(1):30-33
34. D'Alfonso T, Liu YF, Monni S et al (2010) Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed. Am J Surg Pathol 34(4):575-581
35. Uy GB, Laudico AV, Carnate JM Jr et al (2010) Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients. Clin Breast Cancer 10(2):154-159
36. Khoury T, Zakharia Y, Tan W et al (2011) Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsy. Breast J 17(2):180-186
37. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level metaanalysis of randomised trials. Lancet 378(9793):771-784
38. Early Breast Cancer Trialists' Collaborative Group (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100000 women in 123 randomised trials. Lancet 379(9814):432-444
39. Slamon D, Eiermann W, Robert N et al (2011) Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365(14):1273-1283
40. Baselga J, Campone M, Piccart M et al (2012) Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med 366:520-529
41. Baselga J, Cortés J, Kim SB et al (2012) Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. N Engl J Med 366:109-119
42. Hammond ME, Hayes DF, Dowsett M et al (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28(16):2784-2795
43. Douglas-Jones AG, Collett N, Morgan JM et al (2001) Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma. J Clin Pathol 54(12):951-955
44. Wolff AC, Hammond ME, Schwartz JN et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118-145